Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism

PURPOSE: This study investigated the clinical outcomes and safety of apatinib mesylate in the treatment of advanced non-squamous non-small cell lung cancer (NSCLC) in patients who progressed after standard therapy, and analyzed the kinase insert domain receptor (KDR) gene polymorphism. METHODS: A to...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zi-Zheng, Zhao, Li-Fen, Zuo, Jing, Fan, Zhi-Song, Wang, Long, Wang, Yu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982468/
https://www.ncbi.nlm.nih.gov/pubmed/32021302
http://dx.doi.org/10.2147/OTT.S222985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982468/
https://www.ncbi.nlm.nih.gov/pubmed/32021302
http://dx.doi.org/10.2147/OTT.S222985

Ejemplares similares